CMT-SETX

SETX | 2004

What Is CMT-SETX?

CMT-SETX is a type of CMT caused by autosomal recessive mutations in the SETX gene. This gene provides instructions for making senataxin, a protein involved in the processing of RNA and the maintenance of nerve cells. Mutations in the SETX gene disrupt this function, leading to impaired nerve signal transmission.

CMT-SETX is autosomal recessive, meaning that both copies of the gene must have a mutation to cause this subtype.

Clinical Features

The age of symptom onset in CMT-SETX is variable, ranging from childhood to adulthood. Symptoms typically begin in the lower extremities and progress over time to involve the upper limbs. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

CMT-SETX symptoms may include:

  • Weakness in the feet and lower legs
  • Muscle atrophy
  • Foot drop
  • Brisk reflexes
  • Reduced sensation
  • A steppage-style walking pattern
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Progressive involvement of the hands and forearms
  • Difficulty with fine motor skills and manual dexterity
  • Additional symptoms not listed here

Disease Course

CMT-SETX shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
CMT-SETX

Classification
Unclassified Subtypes

Neuropathy Type
Axonal

Inheritance Pattern
autosomal recessive

Genetic Context

HGNC-Approved Gene Symbol
SETX

Gene Full Name
Senataxin

Chromosome
9q34.13

Zygosity of Responsible Variant
Homozygous or Compound Heterozygous

Variant Mechanism

Loss of Function (LoF)

Details

Mechanistic basis:
Biallelic

Confidence:
Medium

Prediction:
The literature predicts a biallelic loss-of-function mechanism for CMT-SETX: two SETX null or hypomorphic alleles reduce senataxin, an RNA/DNA helicase involved in transcription termination and R-loop resolution, below a functional threshold, so restored wild-type senataxin is predicted to rescue. This contrasts with the distinct dominant SETX gain-of-function subtype, judged separately.

Rationale:
Recessive CMT-SETX arises from two null or hypomorphic SETX alleles dropping senataxin helicase activity below a functional threshold, so restored wild-type is predicted to rescue: a biallelic loss of function, distinct from the separately judged dominant SETX gain-of-function disease.

ClinVar Pathogenic Variants

View CMT-SETX ClinVar Variants

SETX OMIM Entry

SETX OMIM

More Info

CMT-SETX Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

DNA/RNA Helicase Gene Mutations in a Form of Juvenile Amyotrophic Lateral Sclerosis (ALS4).
“Dominant mutations in SETX cause HMN/ALS4 (Chen and el., 2004)”
–Inherited Neuropathies Consortium (INC), CMT in Depth: Hereditary Motor Neuropathies – https://www1.rarediseasesnetwork.org/cms/inc/Healthcare-Professionals/CMT

Authors

Chen, Y. Z., Bennett, C. L., Huynh, H. M., Blair, I. P., Puls, I., Irobi, J., Dierick, I., Abel, A., Kennerson, M. L., Rabin, B. A., Nicholson, G. A., Auer-Grumbach, M., Wagner, K., De Jonghe, P., Griffin, J. W., Fischbeck, K. H., Timmerman, V., Cornblath, D. R., & Chance, P. F.

Publication Date
June 1, 2004

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


Jean-Martin Charcot lecturing at the Salpêtrière while comparing anatomical illustrations of a cavovarus Charcot-Marie-Tooth (CMT) foot and a Charcot neuroarthropathy foot, highlighting two different conditions that share the Charcot name.


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


Close-up of a doctor’s hand holding a prescription pad while a patient’s wrist is wrapped with metal chains.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Illustrated graphic showing large ‘404’ numerals with people interacting with data screens and servers, alongside text reading ‘CMT Genetic Testing Error 404: Gene Not Found’ and ‘Examining Why Less Than Half of All Who Have Charcot-Marie-Tooth Disease Are Not Able to Obtain Genetic Confirmation of Their Disease.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.